BCL9L and pancreatic neoplasm: In order to study the functional relevance of BCL9L up-regulation in pancreatic cancer, its expression was stably silenced in Panc-1 cells using two different shRNAs targeting the coding sequence (CDS; shBCL9L_1), and the 3′UTR (shBCL9L_2), respectively.